ObsEva SA
(NASDAQ : OBSV)

( )
OBSV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.17%144.680.7%$933.18m
PFEPfizer Inc. -0.58%35.790.9%$910.95m
MRKMerck & Co., Inc. 0.65%83.170.7%$706.80m
ABBVAbbVie, Inc. -1.41%85.911.9%$642.88m
BMYBristol-Myers Squibb Co. -1.25%58.251.0%$602.55m
LLYEli Lilly & Co. -0.55%148.991.1%$553.23m
AZNAstraZeneca Plc -2.68%54.171.2%$243.72m
NVSNovartis AG -1.32%86.300.2%$163.10m
GSKGlaxoSmithKline Plc -1.11%37.370.2%$102.00m
PRNBPrincipia Biopharma, Inc. 0.00%99.950.0%$95.66m
NVONovo Nordisk A/S -1.59%68.300.1%$56.11m
SNYSanofi 0.36%50.790.2%$48.84m
RGENRepligen Corp. -1.71%139.947.1%$47.40m
OPKOPKO Health, Inc. 0.66%3.0711.2%$45.24m
RPRXRoyalty Pharma Plc -3.71%40.230.2%$42.74m

Company Profile

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.